Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Alessandro Loglio
Diagnosed Patients With Chronic Hepatitis B and Delta Virus in Italy in 2024: An Estimation From a National Real‐World Database
ALT alanine aminotransferase ASL regional health authorities CHB chronic hepatitis B CHD chronic hepatitis D HBIG anti-HBs immunoglobulins HCC hepatocellular carcinoma LT liver transplantation NA nucleos(t)ide analogs qHBsAg quantitative hepatitis B surface antigen In Italy, there is no universal screening program for HBsAg nor a registry for patients diagnosed with HBV.
Hepatitis B Immunoglobulins Withdrawal in Hepatitis B Virus Mono‐Infected Liver Transplant Recipients: An Italian Multicentre Prospective Study
ELITA European liver and intestine transplantation association ELTR European liver transplantation registry ETV entecavir EVL everolimus HBIG hepatitis B immunoglobulins HBV hepatitis B virus HCC hepatocellular carcinoma HDV hepatitis D virus hgb-NA high genetic barrier nucleos(t)idic analogue LAM lamivudine LFTs liver function tests LGB low genetic barrier LLOD lower limit of detection LT liver transplantation MMF mycophenolate mofetil NAs nucleoside or nucleotide analogues TAF tenofovir...
Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) after Liver Transplantation: A Narrative Review of an Emerging Issue
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Long‐term endoscopic surveillance in HBV compensated cirrhotic patients treated with Tenofovir or Entecavir for 11 years
ORIGINAL ARTICLE The Handling Editor for this article was Professor Grace Wong, and it was accepted for publication after full peer-review Summary Background Long-term administration of TDF/ETV in patients with HBV-related compensated cirrhosis reduces HCC and decompensation events but the effect of this regimen on development/regression of oesophageal varices (EV) is currently unknown. Aim To assess the risk of EV development/progression in this population.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Alessandro
Contact Alessandro, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack